Researchers in the U.S. have demonstrated that they can efficiently improve the DNA of human embryos using the gene-editing technique CRISPR.
Genome-Wide Cancer 'Dependency Map' Revealed
Genome-Wide Cancer 'Dependency Map' RevealedInitial results reveal more than 760 genetic dependencies across multiple cancers, suggesting opportunities for developing new treatments.
Compound Shows Promise in Treating Melanoma
Compound Shows Promise in Treating MelanomaResearchers take a step towards creating a drug that can kill melanoma cancer cells without harming nearby healthy cells.
Human Embryos Edited for the First Time in U.S.
Human Embryos Edited for the First Time in U.S.Researchers in the U.S. have demonstrated that they can efficiently improve the DNA of human embryos using the gene-editing technique CRISPR.
Autism Severity Detected with Brain Activity Test
Autism Severity Detected with Brain Activity TestChildren with autism have a tell-tale difference on brain tests compared with other children, researchers from the University of California have discovered.
French biotech Cellectis has announced that the European Patent Office has granted them a patent to use CRISPR in T cells.
After a car crash left him with a cervical spine injury, Kristopher Boesen regained motor control after receiving a new procedure, involving stem cells.
Interleukin Genetics has announced its plans to liquidate its assets, following the news that it will be laying off 63% of its workforce.
National security community takes a closer look at the risks and benefits associated with gene drives, a genetic engineering technology.
Methicillin-resistant Staphylococcus aureus (MRSA) actually emerged several years before doctors used methicillin in clinical practice in the late 1950s.
In this issue of the magazine we talk all things cancer, and preview Festival of Genomics San Diego
Download the Clinical Genomics 101, our handy (free) guide to the clinical workflow from sample collection through to data interpretation
Download the Gene Editing 101, our handy (free) guide to the world of gene editing, from controversial issues to enormous medical potential
The Short Read
Luke Timmerman is an award-winning journalist, and the founder and editor of Timmerman Report. We chose him to be this week’s Short Read star.
As the very first employee at Front Line Genomics, he’s seen the company grow from the very beginning. We’ve chosen to grill him in The Short Read
Robert Green is one of those who’s taken it to heart to generate the clinical utility data necessary to integrate genomics into healthcare.
Webinars & Media
Learn about novel approaches in addressing the current trends in Big Data, Analytics and Cognitive Computing in tomorrows webinar.
Industry thought leader will discuss his first of its kind work to demonstrate the uptake of blood-based testing for actionable mutations in a non-hospital setting
Explore how Oxford Nanopore Technologies develop their MinION based infectious diseases diagnostics pipelines with examples from ongoing research on pneumonia, sepsis and UTIs
From the Community
Getting closer to researchers to realise the full potential of NGS, Beckman Coulter Life Sciences are building a new wave of innovation
Two leading advocates propose a 1-billion-dollar investment over the next ten years in hopes to resolve issues of trust and increase minority participation in research dramatically. This is their plan
Taha Kass-Hout was the FDA’s first Chief Health Informatics Officer. Why isn’t he still at the FDA? He has accomplished what he set out to do.
Managing Director at Viveo Ltd., Marina Hop, gives her opinion on why sales in Life Sciences isn’t always easy and what you can do to improve your lead-to-sale rate
It’s up to us to engage with people and make a compelling case as to why science is need to know, rather than nice to know. #MarchforScience
As a bench scientist, or perhaps a laboratory clinician, be honest now: how often have you thought about how critical your pipette tips really are?
In the Press
Initial results reveal more than 760 genetic dependencies across multiple cancers, suggesting opportunities for developing new treatments.
Researchers take a step towards creating a drug that can kill melanoma cancer cells without harming nearby healthy cells.
Children with autism have a tell-tale difference on brain tests compared with other children, researchers from the University of California have discovered.
Damage to cell’s genetic material can trigger inflammation, enabling processes to remove damaged cells and keep tissues healthy.
Engineers have developed a set of hydrogel-based drug delivery materials, which can live in the stomach for nine days, that slowly release medication.
A new study reveals that a favoured method for measuring microbial biodiversity is not as accurate as previously thought.
Here are 5 stories worth reading before shutting your brain off before the weekend.
Have you attempted to try out some tennis lingo the past week, and you don’t really know what it means? The tournament is over on Sunday. Phew!
It’s sunny outside, it’s warm, and it’s Friday. We all want to leave early – maybe you’re one of those who’s already on their way home from the office?
SeraCare has developed a unique patent-pending technology that produces a DNA fragment size-distribution which closely mimics native cfDNA
Researchers explore how the discoveries of basic knowledge and technologies that can alter our genes, cells and tissues may affect what it means to be human.
Reading this summer? Our own Staff Writer, Frances reviews and gives the book Perfect People by Peter James 2.5/5 stars.